Difference on the levels of Nesfatin-1, C-reactive protein and serum ferritin in different gestational periods in patiens with gestational diabetes mellitus and their relationship
JIANG Haiying ZUO Jinling SANG Xuemei WANG Qian ZHAO Jing
Department of Gynaceology and Obstetrics, Maternal and Child Health Hospital of Tangshan, Heibei Province, TangShan 063000, China
Abstract：Objective To investigate the levels of Nesfatin-1, C-reactive protein (CRP) and serum ferritin (SF) of different gestational periods in patients with gestational diabetes mellitus (GDM) and their relationship. Methods From June 2015 to January 2017, 103 patients in early pregnancy built profile and examined in Maternal and Child Health Hospital of Tangshan were selected as research objects and divided into the test group (47 cases) and the control group (56 cases) by the oral glucose tolerance test. The general conditions (includes age, gestational weeks, BMI, fasting blood glucose and fasting insulin) in middle pregnancy between the two groups were compared and the levels of Nesfatin-1, CRP and SF in the early and middle pregnancy between the two groups were compared. The logistic regression analysis was used to analyze the related factors of GDM. Results There were no statistically significant differences in the age, gestational weeks and BMI between the two groups in the middle pregnancy (P ＞ 0.05). The fasting blood glucose and fasting insulin in the test group were higher than those of control group, with statistically significant differences(P ＜ 0.05). In the early and middle pregnancy, the levels of Nesfatin-1, CRP and SF in the test group were higher than those of control group, with statistically significant differences (P ＜ 0.05). In the test group, the indicators above in the middle pregnany were higher than those of early pregnany, with statistically significant differences (P ＜ 0.05); in the control group, there were no statistically significant differences in the above indicators between the early and middle pregnany (P ＜ 0.05). The Logistic regressive analysis showed that the fasting blood glucose, fasting insulin, Nesfatin-1,CRP and SF were the risk factors of GDM (P ＜ 0.05). Conclusion Serum Nesfatin-1, CRP and SF are the risk factors of GDM. In early pregnancy of GDM patients, Nesfatin-1, CRP and SF are higher than those in normal pregnant women and it is helpful for early detection of GDM, so as to control the patients′ blood glucose effectively, which is of great significance to improve the pregnancy outcome.
姜海英 左金玲 桑雪梅 王茜 赵竞. 不同孕期Nesfatin-1、C-反应蛋白及血清铁蛋白水平差异及与妊娠期糖尿病的关系[J]. 中国医药导报, 2018, 15(6): 98-101,105.
JIANG Haiying ZUO Jinling SANG Xuemei WANG Qian ZHAO Jing. Difference on the levels of Nesfatin-1, C-reactive protein and serum ferritin in different gestational periods in patiens with gestational diabetes mellitus and their relationship. 中国医药导报, 2018, 15(6): 98-101,105.
[1] 蔡慧华，何援利，王雪峰，等.糖化血红蛋白联合空腹血糖检测在妊娠期糖尿病筛查中的应用价值[J].实用妇产科杂志，2014，30（3）：205-208.
[2] Dijigow FB，Paganoti CF，Costa RA，et al. The influence of breastfeeding in postpartum oral glucose tolerance test in women with recent gestational diabetes mellitus [J]. Rev Bras Ginecol Obstet，2015，37（12）：565-570.
[3] 左晓红，王文.葡萄糖氧化酶法用于测定糖尿病患者口服葡萄糖耐量试验的研究[J].宁夏医科大学学报，2015， 37（1）：78-80.
[4] 潘宝龙，马润玫.血清脂肪因子omentin-1、chemerin的水平与妊娠期糖尿病的相关性[J].南方医科大学学报，2016，36（9）：1231-1236.
[5] Wilk M，Horodnicka-Józwa A，Mol?説da P，et al. Assessment of selected anthropometric parameters in children exposed to gestational diabetes in utero-preliminary results [J]. Pediatr Endocrinol Diabetes Metab，2015，20（2）：40-46.
[6] 王心，李冰，尚丽新.妊娠期糖尿病患者血清Nesfatin-1水平及糖脂代谢紊乱的相关性[J].中国优生与遗传杂志，2015，23（9）：62-64.
[7] 张克良，刘大成，孟小望，等.2型糖尿病患者强化治疗前后血清铁变化与胰岛素抵抗的关系[J].中国糖尿病杂志，2017，25（5）：411-414.
[8] 杨慧霞.妊娠合并糖尿病诊治指南（2014）（一）[J].中华妇产科杂志，2014，49（8）：78-82.
[9] 王爽，杨慧霞.妊娠期糖尿病发病的危险因素分析[J].中华妇产科杂志，2014，49（5）：321-324.
[10] 谢幸，苟文丽.妇产科学[M].8版.北京：人民卫生出版社，2013.
[11] Shin MK，Kim YS，Kim JH，et al. Dietary Patterns and Their Associations with the Diet Quality Index-International（DQI-I）in Korean Women with Gestational Diabetes Mellitus [J]. Clin Nutr Res，2015，4（4）：216-224.
[12] Mert M，Purcu S，Soyluk O，et al. The relationship between glycated hemoglobin and blood glucose levels of 75 and 100 gram oral glucose tolerance test during gestational diabetes diagnosis [J]. Int J Clin Exp Med，2015， 8（8）：13335-13340.
[13] 文东虎，刘佳，王晓鑫.妊娠糖尿病患者胰岛素抵抗及胰岛细胞功能与FGF21、Nesfatin-1的相关性分析[J].中国妇幼保健，2015，30（19）：3297-3299.
[14] 徐菁.妊娠期糖尿病危险因素分析及患者血清RBP4、leptin、Nesfatin-1水平变化[J].中国实验诊断学，2017， 21（3）：448-451.
[15] Iimura Y，Matsuura M，Yao Z，et al. Lack of predictive power of plasma lipids or lipoproteins for gestational diabetes mellitus in Japanese women [J]. J Diabetes Investig，2015，6（6）：640-646.
[16] 黄聪，黄顺彬，王艳君.妊娠期糖尿病患者血清RBP4和SF的表达及与胰岛素抵抗的关系研究[J].中国妇幼保健，2016，31（22）：4629-4631.
[17] 叶绥艳，刘晓莺.血清SF和hs-CRP水平在妊娠期糖尿病患者中的诊断价值[J].检验医学与临床，2016，13（21）：3081-3083.
[18] 许曼，李丽贤，廖义鸿.妊娠糖尿病脂联素、炎性因子与胰岛素抵抗相关性分析[J].中国实用医刊，2016，43（24）：76-78.
[19] 冯咏梅.围产期营养门诊对妊娠期糖尿病患者胰岛素敏感性、胎盘及脂肪组织中炎症反应的影响[J].海南医学院学报，2017，23（14）：1934-1937.
[20] 张少容，卢丹红，刘丽萍.个体化饮食干预对妊娠期糖尿病孕妇血糖控制效果及妊娠结局的影响[J].中国医药科学，2016，6（12）：62-65.
[21] 钟艳萍，邢彦君，赵卓姝.体重指数管理及血糖控制对妊娠期糖尿病孕妇围产结局的影响[J].中国医药科学，2016，6（16）：117-119.
[22] 莫琴，胡翔，林丽妮，等.妊娠早中期个体化医学营养管理降低妊娠期糖尿病发生率作用的研究[J].中国医药科学，2017，7（12）：187-191，198.
[23] 陈爱妮.妊娠期糖尿病危险因素及血糖控制分组对妊娠结局的影响[J].中国医药科学，2017，7（16）：87-89， 93.
[24] 梁华铭.妊娠期糖尿病孕妇血清25-羟维生素D水平及胰岛素抵抗的相关性分析[J].中国医药科学，2016，6（12）：77-79，114.
[25] 侯雪晶，孙燕，陈秀英.妊娠期糖尿病与肥胖症、炎症因子、25-（OH）D3和胰岛素抵抗的关系[J].中国热带医学，2016，16（3）：262-265.
2018, Vol. 15 
京公网安备 11010502046598号